Wird geladen...
Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
PURPOSE: To report our experience with dexamethasone 0.7 mg sustained-release intravitreal implant (Ozurdex(®); Allergan, Inc, Irvine, CA) in noninfectious posterior uveitis. METHODS: A retrospective chart review of patients with noninfectious uveitis treated with sustained-release dexamethasone 0.7...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove Medical Press
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3000767/ https://ncbi.nlm.nih.gov/pubmed/21188153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S15696 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|